Biotech · Private company
GPCR Therapeutics, Inc.
Track this companyFree. Adds GPCR Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- G-CSFPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- GPC-100Phase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- PropranololPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- TG-0054Phase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- TG-0054 combined with G-CSFPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- TG-0054Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantPHASE2 · COMPLETED · started Feb 13, 2023ClinicalTrials.gov NCT05561751 · fetched Nov 12, 2026
- PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease PatientsPHASE2 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02104427 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin DiseasePHASE2 · COMPLETED · started Oct 1, 2012ClinicalTrials.gov NCT01458288 · fetched Nov 12, 2026
- Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy VolunteersPHASE1 · COMPLETED · started Apr 1, 2008ClinicalTrials.gov NCT00822341 · fetched Nov 12, 2026